Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Vaccine Locations | Will County Health Department
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
Know Your Vaccines (Vaccine Matrix: Current Evidence) | Department of Health website
Information for Pharmacists: Everything You Need to Know about the COVID Vaccines
FDA Authorizes 3rd Dose of Pfizer Vaccine for Immunocompromised Kids — Children's Cancer Cause
Coronavirus vaccination: the most important questions and answers
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
1) Why should children and adolescents aged 6 months to 17 years receive COVID-19 vaccine? In the early stage of the COVID-19
What is the recommended interval between doses? - MOH FAQ - AskGov
EU now advises 3-week interval between Pfizer vaccine doses | Reuters
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Chart: 28 Days Later: The Pfizer/BioNTech Vaccination Process | Statista
.jpg "Researchers encourage longer dosing intervals for Pfizer-BioNTech's COVID-19 vaccine")
Researchers encourage longer dosing intervals for Pfizer-BioNTech's COVID-19 vaccine
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Information for Pharmacists: Everything You Need to Know about the COVID Vaccines
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
Testing fractional doses of COVID-19 vaccines | PNAS
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
2021-07-07-grafik-impfstoffe.png
Singapore OKs Covid vaccine for children, outlines inoculation plan
